JNJ

Johnson & Johnson · VIE:JNJ

239.80 EUR−7.00 −2.84%

Johnson & Johnson (VIE:JNJ) last traded at 239.80 EUR, down 2.84% on the day. Over the past year the stock is up 47.37%. Its 52-week range is 160.64 to 251.25. It is in the Health Technology sector (Pharmaceuticals: Major).

Key statistics

Open243.85

Day range239.40 – 243.85

52-week range160.64 – 251.25

Volume33

Average volume (10 days)24

Market cap (USD)657.68 B

P/E41.21

EPS (TTM) (USD)6.59

Dividend yield1.93%

Beta (1 year)−0.2404

Revenue (TTM) (USD)99.35 B

Employees140.80 K

Performance

+1.05%1 week

+3.92%1 month

+8.43%3 months

+24.68%6 months

+36.34%Year to date

+47.37%1 year

Technical reading

Bullish

Daily summary of what 11 oscillators and 15 moving averages show. See every indicator

Latest headlines

Johnson & Johnson reports 94% success rate in trial of coronary artery deviceSeeking Alpha · 01 Nov 2026
Johnson & Johnson reports lower mortality rates with Impella heart pumpsSeeking Alpha · 01 Nov 2026
J&J Reports Positive Survival And Outcomes With Impella In HrpciReuters · 01 Nov 2026
Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study ResultsBusinessWire · 01 Nov 2026
Ayushman Bharat Digital Mission Can Transform Healthcare Through Data, Says NITI Aayog MemberBusinessworld · 01 Nov 2026
JNJ's MedTech Segment Disappoints in Q3: Will Growth Rebound in Q4?Zacks · 30 Oct 2026
Experts red-flag cancer drug price cuts as patented therapies see zero relief, markups exceed benchmarkMint · 29 Oct 2026
Over 100 of the 600-plus medicines listed by NPPA do not show a drop in pricesBusiness Line · 29 Oct 2026

Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.